Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
18.95
-0.07 (-0.37%)
At close: Mar 13, 2026, 4:00 PM EDT
18.93
-0.02 (-0.11%)
After-hours: Mar 13, 2026, 5:17 PM EDT

Eton Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
50835611371106198
Market Cap Growth
26.69%216.20%57.37%-32.32%-46.55%53.56%
Enterprise Value
501.41370.7591.1560.6896.52183.51
Last Close Price
18.9513.324.382.824.298.13
PE Ratio
--88.80-109.50-7.83-53.62-6.11
Forward PE
26.02---9.98-
PS Ratio
7.229.123.563.364.845068.29
PB Ratio
21.9514.567.275.475.9912.62
P/TBV Ratio
21.8814.127.265.426.1310.91
P/FCF Ratio
24.16377.2716.5114.95-22.34-8.83
P/OCF Ratio
23.82367.1516.5114.83-22.38-8.85
EV/Sales Ratio
7.139.502.882.864.424705.39
EV/EBITDA Ratio
106.21-255.51-313.22-9.36-93.43-6.94
EV/EBIT Ratio
355.86-142.76-76.47-7.35-64.56-6.77
EV/FCF Ratio
23.86393.1613.3712.69-20.41-8.19
Debt / Equity Ratio
1.331.220.000.420.300.46
Debt / EBITDA Ratio
43.88-20.62-18.56-1.01-6.48-0.27
Debt / FCF Ratio
1.4731.730.791.36-1.41-0.32
Net Debt / Equity Ratio
-0.270.61-1.03-0.75-0.44-0.90
Net Debt / EBITDA Ratio
-8.93-10.3254.941.517.470.54
Net Debt / FCF Ratio
-0.3015.89-2.35-2.041.630.63
Asset Turnover
0.780.721.110.810.810.00
Inventory Turnover
2.131.9314.4212.533.160.54
Quick Ratio
1.141.021.532.814.365.63
Current Ratio
1.632.061.653.105.186.51
Return on Equity (ROE)
-28.10%-19.16%-6.56%-58.75%-11.74%-213.41%
Return on Assets (ROA)
-2.88%-4.80%-2.69%-31.47%-5.56%-124.96%
Return on Invested Capital (ROIC)
-7.73%-12.70%-54.86%-125.00%-26.16%-1190.91%
Return on Capital Employed (ROCE)
-4.60%-7.25%-7.00%-39.83%-6.58%-144.08%
Earnings Yield
-1.32%-1.13%-0.91%-12.77%-1.86%-16.36%
FCF Yield
4.14%0.27%6.06%6.69%-4.48%-11.33%
Buyback Yield / Dilution
-1.46%-2.37%-0.18%-0.35%-0.51%-14.75%
Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q